The aim of this study was to recapitulate ameloblastoma in acompletely humanised 3D disease model containing ameloblastoma cells,osteoblasts and activated osteoclasts to investigate the RANKL pathway withinthe ameloblastoma stromal environment and its response to the RANKL antibodydenosumab. Here, TNFSF11 is linked to ameloblastoma.